The Open Enrollment Period (OEP), a time for making changes to Medicare Part D drug coverage, ended on December 7. Heading into the OEP, there was considerable excitement because the Inflation Reduction Act (IRA) was going to save seniors millions of dollars. But how did that play out in real time?
As I do every year, I studied the 2023 OEP reviews for 65 Incorporated clients. I found that 65% had at least one significant reason to change drug plans.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased